Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA. 2013/05
7.
総説
炎症性腸疾患-過敏性腸症候群・潰瘍性大腸炎・クローン病 2013/09
8.
原著
Questionnaire based assessment of patients' acceptability of leukocytapheresis for the treatment of inflammatory bowel disease. 2013/10
9.
総説
タキサン系抗癌剤による虚血性大腸炎の2例 2013/11
10.
総説
IBD治療のピットフォール(第1回) クローン病出血例に対する治療戦略 2014/03
11.
原著
Prospective postsurgical capsule endoscopy in patients with Crohn's disease 2014/03
12.
原著
Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profile. 2014/06
13.
総説
難治性潰瘍性大腸炎に対する抗TNF-α抗体療法の治療戦略 2014/06
14.
総説
抗菌剤起因性急性出血性腸炎 2014/07
15.
原著
A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis. 2014/09
16.
総説
治療指針・ガイドラインの実臨床への用い方 2015/02
17.
総説
抗TNF-α抗体製剤をどう使うか-その治療戦略 2015/08
18.
総説
コルチコステロイド 2016/06
19.
総説
血球成分除去療法による難治性潰瘍性大腸炎の治療戦略 2016/06
20.
総説
抗TNF-α抗体製剤に起因する皮膚病変 2016/07
21.
原著
Granulomonocytapheresis as a cell-based therapy in an ulcerative colitis patient complicated by aminosalicylate-induced severe lymphocytopenia and pneumonia. 2016/09
22.
原著
Genetic instability, CpG island methylator phenotype, and proliferative activity are distinct differences between diminutive and small tubular adenoma of the colorectum. 2016/10
NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases. 2017/07
29.
原著
Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case series. 2017/12
Association between autoantibodies against the gastric proliferative zone and inflammatory bowel disease (ポスター,一般) 2013/02/15
8.
Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis (ポスター,一般) 2013/02/15
9.
Predictive factors of refractory to tacrolimus therapy in patients with active ulcerative colitis (ポスター,一般) 2013/02/15
A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury in subjects taking low-dose aspirin with or without clopidogrel (ポスター,一般) 2013/05/18
17.
Effectiveness of a new type ultrathin colonoscope in colonoscopy of patients with active ulcerative colitis (ポスター,一般) 2013/05/18
18.
The predictive factors for refractory status and readmission after tacrolimus treatment in patients with active ulcerative colitis (ポスター,一般) 2013/05/21
A report on the prevalence and reactivation rate of hepatitis B virus in patients with inflammatory bowel disease in Japan (ポスター,一般) 2014/02/21
43.
α Infliximab remission induction therapy in patients with ulcerative colitis: Does tumour necrosis factor- α receptor blockade per se explain its multiple actions? (ポスター,一般) 2014/02/21
44.
A report on the prevalence and reactivation rate of hepatitis b virus in patients with inflammatory bowel disease in Japan (ポスター) 2014/05/03
THE CLINICAL OUTCOMES OF 165 ENDOSCOPIC BALLOON DILATATION FOR ILEOCOLONIC OR CAECAL STRICTURES IN PATIENTS WITH CROHN'S DISEASE (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2015/10/28
Pregnancy Outcomes in Patients with Inflammatory Bowel Disease Experiencing Flare ups During Foetal Development (ポスター,一般) 2016/05/22
81.
Factors Associated With Restenosis and the Need for Surgical Interventions in Patients With Crohn`s Disease Undergoing Endoscopic Balloon Dilatation for Lower Gastrointestinal Strictures (ポスター,一般) 2016/05/23
82.
Long Term Efficacy and Safety of Thiopurines in Patients With Steroid Dependent Ulcerative Colitis: A Retrospective Investigation (ポスター,一般) 2016/05/23
Efficacy of Adsorptive Granulocyte/Monocyte Apheresis in Inflammatory Bowel Disease Patients Experiencing Loss of Response to Infliximab:A Case Series. (ポスター,一般) 2017/06/17
106.
Thiopurine-induced Leukopenia Is Associated with a Variant in NUDT15, but Not FTO and RUNX1 in Japanese Patients with Inflammatory Bowel Diseases. (口頭発表,一般) 2017/06/17
Clinical and endoscopic features of secondary loss of response caases in patients with Crohns disease treated with infliximab by top down strategy a case control study (ポスター,一般) 2018/02/16
128.
Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real world specialised hospital (ポスター,一般) 2018/02/16
129.
Risk factors analysis for progression of low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis according to the SCENIC terminology (ポスター,一般) 2018/02/16
CLINICAL CHARACTERISTICS AND COMPLICATIONS IN HOSPITALISED ELDERLY PATIENTS WITH ULCERATIVE COLITIS IN A REAL-WORLD SPECIALISED HOSPITAL (ポスター,一般) 2018/06/04
136.
THE INITIAL TROUGH CONCENRTATION AT 36 HOURS AFTER STARTING TACROLIMUS IS IMPORTANT FOR THE PERSONALIZED MEDICINE STRATEGY IN PATIENTS WITH ULCERATIVE COLITIS (ポスター,一般) 2018/06/04
137.
Clinical features of ulcerative colitis complicated by autoimmune hepatitis: a case series in Japan (ポスター,一般) 2018/06/22
138.
Efficacy and related issues of cytapheresis in elderly patients with ulcerative colitis (ポスター,一般) 2018/06/22
Endoscopic features for loss of response in patients with Crohn’s disease who were treated with infliximab by top-down strategy. (ポスター,一般) 2019/03/08
148.
Investigations of the characteristics and efficary of anti-TNFα agents for optimizing treatment in pediatric patients with new-onset Crhon’s disease. (ポスター,一般) 2019/03/08
149.
Risk factors and clinical characteristics for Pneumonia in Japanese Patients with Ulcerative Colitis. (ポスター,一般) 2019/03/08
150.
The initial trough concentration at 36 hours after starting tacrolimus is important for the personalized medicine strategy in patients with ulcerative colitis. (ポスター,一般) 2019/03/08
151.
CLINICAL CHARACTERISTICS AND RISK FACTORS FOR PNEUMOCYSTIS JIROVECII PNEUMONIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. (ポスター,一般) 2019/05/19
152.
Investigations of the characteristics and anti-TNFα agents for optimizing treatment in pediatric patients with new-onset Crohn’s disease. (ポスター,一般) 2019/05/19
EndoScopic Feautures for Loss of Response Cases in Patients With Crohn’s Disease Who Were treated With Infliximab by Top-down Strategy. (ポスター,一般) 2019/06/15
INVESTIGATION OF THE LONG-TERM PROGNOSIS AFTER ENDOSCOPIC BALLOON DILATATION IN PATIENTS WITH CROHN’S DISEASE 2021/05/21
169.
EFFICACY AND SAFETY OF TOFACITINIB TREATMENT FOR 1 YEAR IN JAPANESE PATIENTS WITH ULCERATIVE COLITIS IN A SPECIALIZED IBD CENTER. (一般) 2021/05/22
170.
Efficacy and safety of tofacitinib treatment for one year in Japanese patients with Ulcerative Colitis in a specialized Inflammatory Bowel Disease center. (一般) 2021/07/08